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Abstract
Background: India has the distinction of financing its healthcare mainly through out-of-pocket expenses by individual
families contributing to catastrophic health expenditure and impoverishment. Nearly 70 % of the expenditure is on
medicines purchased at private pharmacies. Patients with chronic ailments are especially affected, as they often need
lifelong medicines. Over the past years in India, there have been several efforts to improve drug availability at
government primary health centres. In this study, we aim to understand health system factors that affect utilisation and
access to generic medicines for people with non-communicable diseases.
Methods: This study aims to understand if (and how) a package of interventions targeting primary health
centres and community participation platforms affect utilisation and access to generic medicines for people
with non-communicable diseases in the current district context in India. This study will employ a quasi-experimental
design and a qualitative theory-driven approach. PHCs will be randomly assigned to one of three arms of the
intervention. In one arm, PHCs will receive inputs to optimise service delivery for non-communicable diseases,
while the second arm will receive an additional package of interventions to strengthen community participation
platforms for improving non-communicable disease care. The third arm will be the control. We will conduct
household and facility surveys, before and after the intervention and will estimate the effect of the intervention by
difference-in-difference analysis. Sample size for measuring effects was calculated based on obtaining at least
30 households for each primary health centre spread across three distance-based clusters. Primary outcomes
include availability and utilisation of medicines at primary health centres and out-of-pocket expenditure for
medicines by non-communicable disease households. Focus group discussions with patients and in-depth
interviews with health workers will also be conducted. Qualitative and process documentation data will be
used to explain how the intervention could have worked.
Discussion: By taking into consideration several health system building blocks and trying to understand how
they interact, our study aims to generate evidence for health planners on how to optimise health services to
improve access to medicines.
Trial registration: Protocol registered on Clinical Trials Registry of India with registration identifier number
CTRI/2015/03/005640 on 17th March 2015.
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Background
Access to medicines
The first point of contact for curative services in India
is typically in the private sector, and often with med-
ical practitioners without a formal medical degree in
modern medicine [1–3]. In most Indian cities and in
rural areas, private healthcare providers manage pa-
tients with chronic diseases deepening health insecur-
ity for the poor [4, 5]. Even in cases where patients
obtain outpatient care in government hospitals, they
often have to purchase medicines from private phar-
macies, either due to frequent stock-out of medicines
at primary health centres (PHC), or poor procurement
and distribution of drugs at higher levels [6, 7]. In
spite of recent efforts through the National Rural
Health Mission to improve utilisation of public ser-
vices and decrease out-of-pocket expenditure (OOP)
on medicines, recent estimates of OOP expenditure
on medicines continues to be as high as 70 %, with
instances of people falling into poverty merely from
paying for outpatient care for non-communicable
diseases (NCD) [8–10].
The poor availability of drugs in public services
is further complicated by inadequate availability of
relatively inexpensive branded or unbranded generic
alternatives in the private pharmacies [11]. In spite of
India’s reputation as a global supplier of generic drugs,
widespread reports of spurious medicines and the lack
of an effective regulatory system for medicines affect
people’s perceptions of quality of these drugs [12–14].
In addition, leadership and management of govern-
ment health services at various levels within the health
system influences access to medicines. The ways in
which health systems organise their governance, re-
sources use, organisation and management of services
as well interact with people are being identified as the
crucial in ensuring access to medicines, especially in
public services [15] (see Fig. 1). Recent efforts at mak-
ing available cheaper generic equivalents of essential
drugs through Jan Aushadhi stores (people’s pharmacy
in Hindi) have shown promising results; the generic
drugs supplied have been reported to be comparable
in quality to their proprietary equivalents [16, 17].
Medicines and primary health care
Among the several approaches to organising care for
NCDs in low- and middle-income countries (LMIC), the
underlying principle is a well-performing primary health
care system that ensures access to essential drugs for
treatment of NCDs [18, 19]. Ensuring availability of
medicines in government PHCs is necessary, but not
sufficient to ensure access to medicines. Several factors
ranging from individual and household perceptions, so-
cietal preferences and health-seeking behaviour to other
factors related to health system, including availability,
but also affordability, quality and management of gov-
ernment health services together characterise a well-
performing health system. A systemic perspective on
how these various factors interact is crucial in strength-
ening public services response to NCDs.
In this study, we aim to study the health system factors
at the sub-district and PHC level that influence access to
medicines for people with NCDs (diabetes and hyperten-
sion) in a rural Indian district setting. In doing so, we
seek to understand how a mixed public-private health
system, which is in the process of strengthening and
decentralisation, such as the one in India responds to
health services strengthening interventions to improve
access to medicines.
Rationale of the study: medicines and NCDs in India
Globally, there has been a lot of focus on the challenges
in organising care for NCDs, especially in LMICs [18].
Recent publications highlight the inability of several
LMIC health systems to deal with the rising needs of
continuous care and follow-up required for patients with
NCDs, as opposed to sporadic and episodic care for in-
fectious diseases [20, 21]. There is increasing pressure
on Indian policymakers at all levels to improve services
for people with NCDs. Recently, a vertical programme,
the National programme for control of cancer, diabetes,
cardiovascular diseases and stroke (NPCDCS) was
launched by the Indian government to address this chal-
lenge [22]. Various state governments in India as well as
the national government have responded favourably
through policies to improve access over the last decade.
We take into consideration the following factors related
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Fig. 1 Problem tree illustrating government health services problems that could drive NCD patients to buy essential drugs from private
pharmacies
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to the policy environment within which this study is be-
ing proposed, thus of importance to the design of the
study and, eventually for the interpretation of its results.
The governments of India and Karnataka have
committed to investing more money in purchasing
generic medicines and improving availability of these
in government-funded/operated generic drug phar-
macies [23, 24].
Recent reforms in Indian government health services
through the National Health Mission (NHM) encourage
community involvement in managing and financing pri-
mary health centres (PHC) through the establishment of
Arogya Raksha Samitis (patient welfare committees).
These committees have a mandate to oversee the PHC
activities, as well as receive financial endowments from
the State for improvements in PHC services.
Methods
Aim, objectives and research questions
Aim
The aim of the study is to understand health system fac-
tors for improving equitable access to quality generic
medicines for patients suffering from non-communicable
diseases in a rural Indian district.
Objectives
1. To understand if (and how) availability of drugs at
government primary health centres (PHC) could be
improved through formation of patient groups
2. To understand if (and how) utilisation, compliance
and quality of care for NCD at government primary
health centres could be improved through training
PHC staff and optimising existing service-delivery
arrangements.
3. To estimate the additional costs for increasing
rational use of medicines and services optimisation
at PHCs
4. To understand the health system factors that
influence utilisation of drugs at government
primary health centres
5. To document the effects on the private sector of
improved drug availability and utilisation in PHCs
Research questions
The main research question of the study is: does a pack-
age of interventions involving health services optimisation
and strengthening community participation platforms at
primary care level improve availability, affordability,
utilisation and compliance of good quality generic drugs
for NCDs in government facilities in Karnataka? If yes;
how, and for whom and under what conditions does this
happen? We further developed five specific sub-questions
in line with the main research question (and our study
objectives listed above) as follows:
1. Does optimisation of health services (announcing
monthly NCD clinic days, increasing consultation
time, providing counselling services and ensuring
continuity of care) improve utilisation of drugs and
their compliance among patients with NCDs?
2. How can existing community participation
arrangements be strengthened to form pressure
groups of patients with chronic diseases at PHCs?
Does this improve availability of drugs at these
PHCs?
3. If NCD patients shift or opt for public sector generic
drugs for NCD care, will their OOP expenditure on
NCD medicines and proportion of total household
expenditure (THE) spent on NCD drugs decrease?
4. Does the routine monitoring of the quality of NCD
drugs strengthen the regulation of other drugs? How
does the quality of drugs provided in government
hospitals compare with those commonly bought
over-the-counter in private pharmacies?
5. How do private pharmacies respond to improved
generic drugs availability and utilisation in
government PHCs? Do the mean prices of essential
NCD drugs and their availability change in response
to improved availability of these in PHCs?
6. What is the marginal cost of strengthening health
systems so that access to medicines can be improved?
Study design and conceptual framework
In this study, we use a quasi-experimental approach along
with a theory-driven evaluation to study an intervention
for improving access to medicines for diabetes and hyper-
tension at PHCs in Tumkur district of Karnataka, India.
We will use a quantitative before-after quasi-experimental
study design to understand determinants of improved ac-
cess to medicines, and a qualitative theory-driven evalu-
ation approach to answer the how questions. All PHCs (39
PHCs) across three selected talukas were randomly
assigned to one of three arms of the intervention. A base-
line and an endline survey of households, PHCs and pri-
vate pharmacies will be conducted for the before-after
quasi-experimental component.
The qualitative component of the study will use a
theory-driven approach to understand and explain the
changes if any, and why the intervention worked for
some (where it did) and not for others (where it did not)
across the three arms of the study. The theory-driven
approach uses successive waves of qualitative data to
refine the programme theory, thus resulting in a con-
textual explanation for how the programme worked in
the given setting [25]. In so doing, we shall generate an
explanatory theory about improving access to medicines
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in local health systems in India especially focusing on
what works, for whom, and under what conditions, and
why. The study design and initial programme theory have
been represented in Fig. 2 and Fig. 3. An initial programme
theory is an explanation of why the programme is ex-
pected to work; it takes into consideration the inputs of
the intervention and the assumptions of the implementers
on how the intervention inputs could result in the ex-
pected outcomes, integrating contextual information from
the implementation setting.
After the completion of the quantitative analysis
(assessing effectiveness of the intervention) and the
qualitative analysis (assessing the plausible reasons for
the intervention working in some places and not in
others), we will integrate the results into a final programme
theory using the conceptual framework for access to
medicines from a health system perspective proposed
by Bigdeli et al. [26]. In Fig. 4, the Tumkur ATM inter-
vention components have been represented in the
Bigdeli et al. access to medicines framework. We will
use this conceptual framework in explaining how the
intervention contributed to improved NCD care in
some settings, with a focus on the PHC and taluka
level dynamic interactions between individual and
institutional factors that contributed to the change,
wherever it occurs.
Health systems interventions and complexity
Health systems interventions are implemented in exist-
ing, open complex adaptive systems [27–29]. This means
that it is very difficult to expect a linear causal chain
relating the inputs of the intervention to the proposed
outcomes. Our proposed intervention shares some char-
acteristics of a complex intervention:
1. Path-dependence and resistance to change:
The mere availability of generic drugs in PHCs
will not automatically change public prescriber
behaviour or community behaviour of seeking
more expensive branded drugs from private
pharmacies. Changes in prescription practices as
well as health seeking behaviour are crucial to
improving access to drugs.
2. Multiple interacting sub-components within
open systems: Health systems are characterised by
several interacting elements that have a dynamic
relationship amongst themselves [30, 31]. For example,
community driven and/or socio-political factors could
push the services into organising care for chronic
diseases. While in one PHC, this could be due to
community demands and power relationships between
community representatives and the local staff, in
another PHC, this could be due to the nature of
the healthcare teams (their intrinsic motivation,
leadership capacity etc.). The outcome we see could
be determined by a dynamic interaction between
several of these interacting sub-components of a
local health system.
Study setting
Tumkur district has 10 talukas with the population of
these talukas ranging from 167,591 (Koratagere) to
596,000 people (Tumkur) [32]. A taluka is an administra-
tive sub-unit of a district and consists of a hospital provid-
ing secondary care supporting a network of primary
health centres (PHC), each PHC catering to a population
of about 25,000 people. The taluka health office consists
of a team of health managers led by the taluka health offi-
cer (THO), who is a doctor and other health workers. The
team at the taluka level is expected to administer and
supervise several PHCs and the taluka hospital, as well as
implement various disease control programmes and other
top-down schemes (such as the National Health Mission).
In spite of several recommendations in favour of a dedi-
cated public health cadre that is trained in public health
management, most Indian states have not incorporated
such a systematic public health management approach
within their health services [33, 34]. The process of decen-
tralised planning and decision-making is also in progress
with the implementation of the NHM, India’s landmark
Fig. 2 Study design of the Access to Medicines study
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health reform that began in 2005. It is within this macro-
context that our intervention is being implemented in
three talukas of Tumkur district. Maternal and child
health programmes and other district interventions have
been known to be influenced by the specific conditions in
the local health system, as well as the nature of leadership
and other characteristics of the management teams in
these health systems [35].
The study is being implemented across the PHCs in
three talukas (see Fig. 4) of Tumkur district of southern
Karnataka. Tumkur is the second largest district in the
state with an area of 10,598 square kilometres and has
a population of 2.67 million of which around 30 % were
in urban areas as of 2011 [32]. There is a mix of
government and private sector, formal and informal
providers as well as a range of single doctor clinics to
secondary and tertiary level hospitals. The details of the
facilities (both government and private) are given in
Table 1. Despite significant achievements in providing
and managing health services, inter-district and intra-
district disparities in health outcomes persist in many
Indian states [36, 37]. A recent government task force
categorized Tumkur as an average district with respect
to health outcomes and health services performance
[38]. In terms of socioeconomic and development indi-
cators, Tumkur could be classified as being one of the
average performance district among the 30 districts of
Karnataka state.
Each PHC has a doctor leading a team of nurses (at
least 1), pharmacist (1), and few support staff with or
Fig. 3 Initial Programme Theory
Fig. 4 Study setting of the ATM project. Map by authors. Base map derived from Global Administrative Areas database (gadm.org) which is licensed
for academic use with attribution
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without a laboratory technician. A PHC caters to
around 20–40 villages with a population ranging from
25,000 to 30,000 people. For every 5–10 villages (ap-
proximately 3000 to 5000 population), a sub-centre
with a nurse-midwife (Auxiliary nurse-midwife, ANM)
caters to reproductive and child health services and a
few other services under the disease-control pro-
grammes. A male health worker caters to one or more
sub-centres. Under the NHM, a married woman of the
village has been trained to function as a community
health worker (Accredited Social Health Activist – ASHA).
The ANM and ASHA are the main outreach staff that
help in coordinating the many community-based activities
of the PHC.
Rapid local health system assessment and choosing
talukas
We conducted a rapid assessment of the performance
of the local health system with respect to its various
building blocks, following the health systems dynam-
ics framework and the Bigdeli et al. framework (see
Fig. 5) [26, 30]. The objective of the assessment was
to exclude talukas, which do not have the basic con-
ditions needed for a medicines-related health systems
intervention such as the one being implemented. We
used the framework to identify various proxy indica-
tors of performance of particular health system do-
mains and excluded talukas that performed poorly
with respect to the central axis of the health systems:
governance, human resources, service delivery and
population. Three talukas were excluded for not hav-
ing the necessary system preparedness for the inter-
vention based on this assessment. The full details of
the process of the rapid local health system assess-
ment are included in Additional file 1.
Of the seven talukas which qualified for the inter-
vention, we randomly chose three talukas using the
online random number generating tool (Available at
http://www.random.org/; see Additional file 2). The three
talukas chosen were Koratagere, Sira and Turuvekere.
Some characteristics of the three talukas are pre-
sented in Table 2. PHCs across the three talukas were
randomly assigned to one of three arms (A, B and C)
of the study intervention. In Arm A, PHCs will re-
ceive a package of interventions to optimise service
Table 1 Health services in Tumkur district [47]
Type of facility Number
District hospital 1
Taluka hospitals 9
Community Health Centres 4
CHCs having functional OT 1
Primary Health Centres (24 × 7) 114 (44 % of all PHCs)
Sub Centres 477
Number of anganwadi centres 3378
Number of private hospitals in the district 106
Number of private clinics with allopathic doctors 96
Number of private hospitals performing LSCS 40
Fig. 5 ATM conceptual framework
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delivery, while Arm B, they will receive Arm A pack-
age as well as an additional package of interventions
to strengthen existing community participation platforms
for organising NCD care at PHC. PHCs in Arm C will
be the control. The package of activities in A, B and C
are described in Table 3. A detailed description of the
intervention and the underlying assumptions behind
the activities proposed is provided in Additional file 3
and step-wise plan of rolling out of the intervention is
presented in Fig. 6.
Data collection and tools
The study tools, study preparation, process of data col-
lection are described below (See also Fig. 7 on the
study timeline). The quantitative data collection in-
cludes household surveys, facility surveys (public and
private pharmacies) and exit interviews at PHCs. The
Table 2 Characteristics of study talukas
Characteristics Koratagere Sira Turuvekere
Area 652 Sq km 1552 Sq km 778 Sq km
Population 160,952 301,473 174,297
Number of private pharmacies 19 30 22
General adult literacy rate 71 % 67 % 73 %
Number of PHCs 11 17 11
Average population per PHC 14,500 18,000 16,000
Number of private hospitals/clinics 21 64 18
Number of PHCs with qualified
MBBS doctors (of) total number of
PHCs in taluka (as on March 2014)
11 of 11 15 of 17 10 of 11
(Source: Census 2011)
Table 3 Description of activities planned under the study intervention arms
Intervention arm Intervention name Intervention input Activities
A Optimise service delivery Orientation training &
workshop for PHC medical
officers
Training on standard treatment guidelines for NCDs,
rational prescription, maintaining treatment cards for




Training on need assessment for medicines, counselling
patients on medicines and their side effects and non-
drug treatment, indenting for medicines and record
keeping at PHCs.
Training workshop for ANMs,
ASHAs and Anganwadi
workers.
Orientation on lifestyle modification for NCD, need for
long-term follow-up and medication for NCD, availability
of free generic medicines for NCD at local PHCs and
ensuring that patients visit the PHC regularly for
follow-up and medicines.
Advocacy and coordination. Coordination and advocacy at state, district and taluka
levels with different stakeholders to ensure supply of
drugs to the PHCs through routine supply chain, district
PIP or utilising local funds (ARS).
B (Optimise service delivery) + Strengthen
existing community participation




Awareness material shall focus on lifestyle modification
for NCD, need for long-term follow-up and medication
for NCD, and availability of free generic medicines for
NCD at local PHCs.
Disseminate material among health workers, local
community groups (ARS, VHSC).
Formation of NCD patient
groups.
To organise NCD patients group meeting and inform
about the importance of regular treatment and the
advantages of generic medicines
BCC at community level. Health worker spreading information leaflets about
diabetes & hypertension, about the designated NCD
check up day event held 1–3 times per year at the PHC.
Information on NCD control will also be displayed at
prominent places in the PHC and local villages
Meeting with ARS members. Orientation of ARS members about their functions and
possibility of utilizing untied funds for purchasing
medicines for NCD and facilitate their interaction with
patient groups and PHC staff
C (Control) No intervention Government existing
programme for NCD control
at primary health centres.
Government’s making effort at improving generic drug
availability.
Private pharmacies cater to many NCD patients.
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Fig. 6 Step-wise rolling out of the study intervention
Fig. 7 Timeline of the Tumkur ATM study
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qualitative component includes focus group discus-
sions (FGD) with district-level officials, PHC staff and
patient groups.
Quantitative data and tools
Household survey tool The household survey tool was
based on the standardised WHO tool to conduct house-
hold survey and measure access and use of medicines
based on a standardised WHO tool included in the
WHO Operational Packages for Monitoring and Asses-
sing Country Pharmaceutical Situations (World Health
Organization [39]; see Additional file 4). The tool mea-
sures basic demographic and household characteristics,
people’s health seeking behaviour, availability of medi-
cines at homes, cost, affordability and appropriate usage
of medicines by the NCD patients in these households.
The questionnaire was adapted to suit the local context
by choosing modules relevant to our study as well as
adapting it for NCDs (the tool is originally designed for
communicable diseases). Our final tool was divided into
six parts to collect routine demographic information,
health seeking behaviour, socio-economic status, percep-
tions on price and quality of NCD drugs and access to
and use of medicines for NCD. We added additional
questions to collect data on utilisation of PHC services
for NCD, out-of-pocket (OOP) expenditure on NCD
drugs, proportion of total health expenditure (THE) on
NCD drugs, compliance with medication and awareness
on generic drug availability at PHC.
Facility survey tool For the facility level survey, we used
a modified version of Level II survey tool included in the
WHO Operational Packages for Monitoring and Asses-
sing Country Pharmaceutical Situations (World Health
Organization [39]; see Additional file 5). This tool shall
be used to collect data from PHCs, private pharmacies
and the district medicines warehouse. For the facility
survey tool, we used the Karnataka state standard treat-
ment guidelines to finalise a list of medicines that are
supposed to be used for NCDs at PHC level. 11 medi-
cines were included in the survey tool.
The facility survey will assess various aspects of NCD
drugs such as the availability of key essential medicines
for diabetes and hypertension, their stock-out duration,
record-keeping at the facility, conservation conditions
and handling of medicines, patient care and prescribing
practices, price, storing, availability of standard treat-
ment guidelines and essential medicines list.
Exit interview tool The exit interview tool will collect
data about average number of dispensed medicines per
prescriptions and the travel cost borne by NCD pa-
tients (see Additional file 6). The tool will assess how
many of the prescribed medicines were dispensed at
the PHC and if the medicines were adequately labelled
(the label should contain the medicine’s name and dos-
age), if the patients knew about the dosage and dur-
ation of all dispensed medicines, and how much the
patient paid out-of-pocket for medicines and/or in
non-diagnostic fees.
This tool was translated to the local language Kannada
and was verified by a native speaker of Kannada. The
tool was further modified based on two phases of piloting
of the tool.
Training of team members and piloting of tool
The first phase of piloting was conducted at two PHCs
outside in a district adjacent to Tumkur. This phase fo-
cused on the way the survey respondents interpreted the
local language questions and the quality of the data.
After the first round of piloting, we invited an external
expert who was familiar with the application of this tool
in Indian settings. We conducted a training workshop to
train all the data collectors in administering the tool.
After the workshop, the expert and the team organized a
second phase of piloting to ensure that the modified tool
is technically sound and to consider any new ethical im-
plications for the changes made. For the second phase,
the data collectors visited a PHC in the neighbouring
district under supervision of the co-investigator. All is-
sues and challenges faced with the interviews both at
household, public and private healthcare facilities were
discussed at length and the tool refined further.
The tool was also presented and discussed with key
actors in state government and the district health team,
and their permission was sought to conduct facility
surveys in the PHCs.
Survey sampling
Quantitative data
Household survey The WHO household survey tool
does not have inclusion criteria related to NCD. Sample
size calculation was based on obtaining at least 30
households per PHC spread across three clusters (a, b
and c with 10 households per cluster; see above). A typ-
ical PHC in Tumkur district has at least five villages in
each cluster, and hence at least 1000 households in each
cluster (approximately 250 households in a village). We
aimed for a total of 1170 households anticipating 30
households per PHCs across the 39 PHCs.
We started the survey at the PHC where we listed all
the villages under the PHC area. These villages were
then divided into the three clusters based on the dis-
tance from the PHC and from each cluster, one village
was randomly chosen. We randomly selected a mini-
mum of 10 NCD households from all four directions
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starting from the central point of the village. After get-
ting informed consent of the participant the survey
questionnaire was administered to the NCD patient for
the interview. In his/her absence, the spouse or another
member of the household who was over 18 years of age,
aware of the information sought in the survey and will-
ing to provide this information was interviewed. The
data collectors started the survey within each village in
four different directions and ensured that all types of
houses and areas within the village were included in the
sampling. Wherever 10 NCD households were not ob-
tained in one village, the data collectors repeated the
process in the nearest adjoining village. Each participant
was provided with an information sheet and health
awareness material in local language related to NCDs
(Additional file 7) as well as contact information of the
research team.
We surveyed 10 households from within five kilometre
radius from the PHC (cluster a), 10 from between five to
10 km radius (cluster b), and 10 from more than 10 km
distance from the PHC (cluster c). All of the 39 PHCs in
these three talukas were covered, resulting in 1069 NCD
households surveyed as presented in Table 4 and Table 5.
The same households shall be sampled during the end-
line survey planned in last quarter of 2015.
Geographic coordinates were captured for each of the
household and facility surveyed using a hand-held global
positioning system (GPS) device (GARMIN model EPX
300). This will enable generation of maps to summarise
the household and facility data using QGIS, a geographic
information system application that allows for geo-
spatial data analysis and mapping (QGIS Version 2.4).
There were PHCs where we could not sample cluster b
and/or cluster c due to their small geographic spread
(see Table 6). In other instances, we sampled sometimes
in excess and sometimes lesser than desired number of
households based on the availability of a NCD patients
in these houses (see Fig. 8). The various households and
facilities (PHCs and private) where data was collected
are represented in Fig. 9. In some instances, where areas
covered by a given PHC were smaller, we could only
identify two distance-based clusters (a and b), as seen in
Koratagere in Fig. 10. Similarly, the sampled households
in Sira are shown in Fig. 11.
The survey form typically took an about 30 min to ad-
minister, and an average of ten questionnaires was given
per field investigator per day. The filled-in forms were
checked for completeness and appropriateness of re-
sponses by a supervisor the same day. In case of incom-
plete forms, the field investigator revisited the households.
To validate the data collection the supervisors randomly
picked one survey form in every 10 forms and visited
the household to check the validity of the data. The
supervisors were provided with structured checklist
(Additional file 8) to ensure completeness of the survey
forms. During the weekly meetings, the study team
reviewed all the collected forms in that particular week,
and discussed any challenges and sought information on
any potential ethical issues.
Facility survey For the facility survey, we sampled from
the district drug warehouse (n = 1), all the PHCs (n = 39)
and the private pharmacy nearest to the PHC (n = 30)
(Table 7). At the private pharmacy, we collected data on
the most sold and least priced generic medicines for
NCDs along with storage conditions and price of the
medicines. Consent was obtained to collect information
at each facility; an information sheet was provided to
the pharmacist at each facility. The stock-out duration
and the indenting price (the cost price) were physically
verified by the research officers in all the facilities.
Exit interviews
A trained data collector conducted exit interviews. At
each PHC, the data collector recruited NCD patients
over a period of three days per PHC for all the PHCs
(n = 39). Each patient exiting the facility was approached.
If the current consultation was for Diabetes/Hypertension,
Table 4 Distribution of households participating in the study
by taluka





Table 5 Number of PHCs covered in the ATM study talukas





Table 6 Distribution of sampled clusters (a, b and c) across the
ATM study talukas









Turuvekere 11 11 11 33
Sira 17 17 14 48
Koratagere 11 10 6 27
Total 39 38 31 108
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then the study details was explained and written consent
obtained to conduct the interview. The target was to inter-
view 30 patients but we were able to conduct, on an aver-
age, eight interviews per PHC over the three days. A daily
debrief was organised by the researchers to identify and
respond to any ethical or operational challenges in course
of the day.
End-line survey After 18 months of the intervention,
the survey will be conducted in the same three talukas.
The same households (panel survey) that participated in
the baseline survey will be visited again with the survey
questionnaire.
Qualitative data
Qualitative data will be collected in two phases; it will be
used on one hand to guide the contextualisation of the
intervention, and on the other hand for a process evalu-
ation of the intervention.
Initially, we used data from focus group discussions
and in-depth interviews with communities and health
managers to contextualise the implementation of the
intervention. The data was also used to prepare an initial
programme theory (how is the intervention supposed to
work). After the implementation of the intervention, we
will use qualitative data to understand why it worked in
some places (where it did) and not in others (where it
did not) through the refining of the initial programme
theory. The refining of the initial programme theory in-
volves critically assessing the assumptions of the initial
programme theory in relation data collected during the
intervention implementation as well as an understanding
of how such interventions are supposed to work in wider
literature. Programme theories can be progressively re-
fined as the intervention is implemented and monitored.
The refined theories generated could be used to under-
stand the relationships between intervention inputs,
local context and the outcomes seen [29, 35, 40].
For developing the initial programme theory, we will
conduct a content analysis of relevant documents in-
cluding project documents, documents and reports of
the National Programme for Control of Diabetes Cardio-
vascular diseases and Stroke, the recently launched na-
tional programme on NCDs and various pharmaceutical
policies at state and national level. The content analysis
will be used along with review of literature and the base-
line qualitative data to build an initial programme theory
on why the intervention is supposed to work and what
possible local factors could be critical for the implemen-
tation of NCD care at PHCs.
In-depth interviews, process documentation during
the implementation of the intervention and another
Fig. 8 Percentage of clusters across study talukas showing sampling adequacy
Fig. 9 Map showing all the sampling points (households, PHC and
private pharmacies) in the Tumkur ATM study. Base map derived
from Global Administrative Areas database (gadm.org) which is
licensed for academic use with attribution
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round of qualitative data collection through focus group
discussions and in-depth interviews at the end of the
intervention period will be used to refine the initial
programme theory and understand the health system
factors that could have contributed to positive outcomes
in PHCs where it did work, and the possible contribu-
tion of the intervention.
Focus group discussions As part of the baseline activ-
ities, we conducted focus group discussions (FGD)
with various stakeholders such as community mem-
bers, health workers, government doctors (PHC med-
ical officers) and pharmacists in private pharmacies. A
total of 13 FGDs were conducted. Each FGD had
about 8–10 participants.
The FGDs among the community members were con-
ducted with an objective of understanding the experi-
ence and identifying barriers in accessing care at PHCs,
more so for patients with NCDs. We in fact tried getting
different perspectives by conducting these FGDs among
Fig. 10 Map showing sampling of households and facilities in Koratagere taluka. In some PHCs with smaller area of coverage, only two
distance-based clusters were identified for the household survey. Base map derived from Open Street Maps layer which is licensed under
creative commons license
Fig. 11 Map showing sampling of households and facilities in Sira taluka. The three distance-based clusters are highlighted. Base map derived
from Open Street Maps layer which is licensed under creative commons license
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diverse groups i.e. men, women, NCD patients, healthy
adults, and people from different socio-economic cat-
egories. The health workers FGD consisted of Accre-
dited Social Health Activist (ASHAs) and Auxiliary
Nurse Midwife (ANMs). The discussions with the PHC
medical officers were conducted separately. These FGDs
focused on PHC doctors’ experiences and challenges in
delivering care for patients suffering from NCDs at pri-
mary care level, including pharmaceutical and behav-
ioural management. Their perspectives on access to
medicines in general and on services delivered at the
PHC were also documented. We invited pharmacists
who owned or operated private pharmacies in Tumkur
town to participate in an FGD. In this FGD, we explored
their perceptions on price and quality of the medicines
supplied both in government and private pharmacies
and also on their view on generic medicines.
All FGDs were audio-taped and transcribed. The par-
ticipation in the FGDs was voluntary and no compensa-
tion was provided to the participants. Informed written
consent was obtained from all FGD participants. All
participants were given written information about the
project. The details of the FGDs conducted in the base-
line phase are in Table 8.
In-depth interviews In-depth interviews were conducted
with various actors in the heath system to understand
their perspectives on different issues around NCD
management and access to medicines. Suggestions
were sought from them on the design and implementa-
tion of the study intervention to improve access to
medicines for NCD patients. The feasibility of the
intervention was discussed and the suggested modifica-
tions were incorporated.
Process documentation
Process documentation forms an integral part of the
qualitative component of this study. Quarterly field visits
will be conducted to the PHCs and data on utilisation of
various services and medicines dispensed for NCDs will
be recorded. The patient experiences, PHC staff atti-
tudes towards NCD patients and details of supervisory
visits from taluka health officials would be captured. The
latter is in order to understand and interpret possibly
taluka-wise differences in local leadership and manage-
ment that could explain differences in performance
between PHCs that have received similar inputs.
The interaction with the providers would focus on the
motivating factors in case of early adopters and the per-
ceived difficulty in case of others. After each such visit, a
detailed narrative report would be prepared. This report
would capture unstructured details about: new changes
or updates regarding NCD patients in the PHC, re-
sponses of PHC staff to the intervention-related devel-
opments such as PHC meetings, sub-centre meetings
and PHC health days (in the intervention PHCs). In the
control PHCs, the field visits will be used to collect new
information on any initiatives to detect or treat NCD
patients and perspectives on the staff on NCD care.
As part of the community level intervention, we will
participate in the patient group meetings and observe
whether the group dynamics and the interaction of the
group with the PHC have changed/improved, this will be
noted and these groups will be purposively approached
during the post-intervention data collection.
Drug quality test
A quality test for NCD medicines has been planned as
an independent activity of the study. Of the 11 drugs
included in the facility survey, four were chosen (two
anti-diabetic and two anti-hypertensive medicines) for
quality testing. Generic and branded medicines were
sampled from both government and private facilities in
the three study talukas, Tumkur district as well as the
nearest big city, Bangalore. The full details of the
sampling and the tests are in Additional file 9.
Data analysis
The quantitative and qualitative analysis will first be
done independent of each other. At the end of the
Table 7 Distribution private pharmacies interviewed across the
study talukas






Table 8 Details of focus group discussions conducted in the baseline phase
S No. Number Group Content Target population
1 2 Patients NCD burden & care NCD patients
2 2 Healthy adults (Non NCD) Quality of health care Non NCD patients & other healthy individuals
3 4 Health workers NCD burden & community awareness ASHAs and ANMs
4 1 Private drug shopkeepers Quality generics for NCD Tumkur district private drug shopkeepers
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baseline survey and during process documentation, the
qualitative data will be analysed iteratively for refining
the programme theory of the intervention.
Data entry and cleaning
The original household survey data were labelled and
stored so that researchers can return to the original
source of the data if necessary. A data entry form with
inbuilt restrictions and validity checks for the fields was
created using Epidata [41]. In addition, 10 % of the data
entered randomly were verified with the survey ques-
tionnaire by a supervisor. Any discrepancy (missing or
illogical values) was corrected by checking the paper
questionnaire and if any crucial missing data, field visits
may be made again, if necessary.
Quantitative data analysis
The quantitative data will be transferred to data analysis
software (SPSS) and basic variables will be created. All
the codes and value labels of the variables will be re-
corded and saved for further use if any. We will create
three datasets from the household survey to capture
basic household, demographic and patient (NCD) level
characteristics. Then, these datasets will be merged and
the merged dataset will be independently validated
through running similar queries on at least two different
statistical analysis software (SPSS and R). Private facility
interview data and PHC interview data will be merged
after cleaning. Exit interview data will be also be cleaned
and analysed separately.
Univariate analysis
Basic tables and graphs depicting summary statistics of
the respondents (individuals, households and patients)
will be done– example percentage of women, age distribu-
tion, caste, religion, type of households, household amen-
ities, number of diabetics and hypertensive, availability of
medicines in the house and health facilities etc.
Bivariate analysis
We will check for association (Chi-square distribution)
and linear and partial correlations among selected vari-
ables in line with the hypotheses/research questions
identified in the research protocol. Baseline and end-line
household and facility level characteristics will be com-
pared across the intervention arms and study talukas.
Intention-to-treat analysis
We will conduct an intention to treat analysis at the PHC
level. Independent variables such as socio-demographic
characteristics will be compared to assess comparability
across intervention arms, using relative risk ratios at base-
line and endline. Like in the cases of classical trial studies,
when the unit of the intervention (PHCs in this study)
does not follow the protocol for their assigned treatment/
intervention, the resultant “treatment contamination” can
produce misleading findings. Intention to treat analysis
will be used in this case to estimate the effect of recom-
mending a treatment to study participants, not the effect
of receiving the treatment. Further a technique called con-
tamination adjusted intention to treat analysis will be
attempted to complement the intention to treat approach
by producing a better estimate of the benefits and harms
of receiving a treatment/intervention [42].
Subgroup analysis
We will analyse various sub-groups like gender, age,
caste, socio-economic category, distance of household
from PHC, in relation to their access to medicines, af-
fordability, or availability of key medicines for previous
six months. We will compare these sub-group character-
istics across intervention arms.
Covariate-adjusted analyses
This analysis will aim at establishing the improvements
(in terms of outcome variables) due to the intervention.
We will take into account the non-equivalence of the
three intervention groups with respect to some baseline
characteristics. This will be examined through logistic
regression. Robust standard errors will be adjusted for
clustering at village level. We will check and compare
adjusted and unadjusted odds ratio while doing the
logistic regression.
Asset index
An asset index will be constructed for the households by
performing principal component analysis on key house-
hold characteristics like household ownership of house,
a two wheeler and domestic animals, utilities used in the
household like tap water inside their houses, access to
electricity or access to other amenities [43, 44].
Difference in difference analysis
Difference in difference estimation will be used to test
the effect of the intervention on the outputs. This ana-
lysis will adjust for the possibility of other factors like
time, institutional factors leading to the output.
Cost-effectiveness analysis
Finally we will analyse the cost data on the expenditure
on the various intervention inputs consisting of human
resources, training, community mobilization, awareness
promotion materials, stationary and overheads. These
costs will be compared with the outcomes (availability
of key generic NCD medicines in PHC, prescription of
generic medicines, regular and rational consumption of
medicines among NCD patients) extrapolated at the
population (NCD) level for the study arms. Incremental
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cost effective ratios will be estimated against the
control arm.
Outcome estimation
Outcomes (see Table 9) will be reported as effects of said
interventions and represented as risk ratios and odds
ratios with 95 % confidence interval.
Qualitative data analysis
All the process documentation data and the baseline
and endline interview transcripts will be managed
through uploading in a secure and password-protected
account in Evernote, a cloud-based data storage soft-
ware that allows for tagging and organising various
forms of data automatically, for place, type of data and
coordinates [45]. This data will be directly imported
into NVivo for coding.
The qualitative data analysis will draw from the
principles of theory-driven approach, in this case
starting with the initial programme theory. We will
analyse the qualitative data by examining the extent
to which the intervention designers’ assumptions were
borne out, especially looking for alignments as well as
contradictions to these programme theory assump-
tions. In doing so, we will borrow from wider litera-
ture on how and why interventions such as this one
have been studied in literature, as well as scanning
our data for micro and meso level contextual factors
that affected programme performance and/or outcomes
[26]. We will thus refine the initial programme theory
enriching it with the contextual understanding of the
intervention in order to explain how the intervention
worked (where it did) and under what conditions it
worked. The resulting refined programme theory at the
end of the intervention will be useful in understanding
how local health systems such as Tumkur respond to
resources that such interventions provide.
Discussion
Understanding the why and how of interventions
Healthcare organisations and systems are complex en-
tities, which do not respond uniformly and predictably
to a given policy. Feedback loops and path dependence
often result in policy failures or inadequate response,
while there could also be unintended and unforeseen
consequences of interventions. We have developed an
intervention based on the gaps in the present health
system that need to be addressed for the above policies
to result in improved access to medicines for people
with NCDs.
Our intervention is being implemented at the district
level in partnership with the district health services. It
could be described as a complex intervention in view of
the involvement of actors at various levels of the health
Table 9 Measures (indicators) for primary and secondary outcome of interest
Factors to be measured Indicator
Primary outcome of interest
Improved and continuous availability of generic drugs at PHC Percentage of PHC where all generic medicines for NCD patients adequately
available in last three months
Increased and regular access to quality medicines for patients
with NCD
Percentage of NCD patients/patient groups visit intervention PHC in last
three months
Out-of-pocket expenses among patients with NCD Percentage reduction in median OOP expenditure on medicines per year among
NCD patients.
The marginal cost of the intervention to that of the outcome Incremental cost effective ratio
Improved compliance to standard treatment guidelines by
the PHC
Percentage MOs followed prescription practices as per the standard treatment
guidelines.
Improved demand of generic drugs among the patients Percentage increase in patients availing generic drugs from the PHC compared
to what it was at three months back
Improved utilization of medicines among NCD patients Percentage of NCD patients/ patient groups obtained complete and regular
medication for last three months.
Secondary outcome of interest
Better coordination among health staffs with regards to NCD
patient group formation
- Percentage increase in number of patient groups formed.
- Percentage increase in number of new diabetes patients registered in last three
months for a given PHC.
- Percentage increase in number of new hypertension patients registered in last
three months for a given PHC.
Better drug procurement Percentage PHCs where drug procurement is up to date for the last quarter.
Conduction of NCD clinics Percentage PHCs conduct NCD days in last three months
Better reporting and recording by the pharmacists at PHC Percentage PHCs where medicines were dispensed as prescribed
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system with varying interests, powers and relationships.
Innovative health services interventions need to be de-
signed in LMICs to better understand the conditions that
could enable improvement in complex health systems.
Hence, integrating experimental study designs (effective-
ness) with qualitative methods (process) is crucial. Our
study provides a model for strengthening health services
for NCDs and identifying the necessary conditions for im-
provements. By taking into consideration several compo-
nents of the health system (governance, service delivery,
resource planning and community) and trying to under-
stand them, our study aims to generate evidence for health
planners on how to optimise health services to improve
access to medicines in a particular kind of setting.
Medicines: from availability to access
In India, as in many other LMICs, various issues hinder
access to medicines. The access issue is more acute for
NCD patients due to their need for lifelong supply. Is-
sues related to procurement, management of supply
chain and the governance of drugs procurement systems
in the state level are crucial to ensuring availability of
medicines at PHCs. Since drugs procurement and supply
is often relatively centralised in many states, those states
that have implemented reforms of their procurement
systems are better-off with respect to ensuring availability
of medicines in PHCs [46]. However, in addition to re-
forms at the state level, district and sub-district level cap-
acity and performance issues are crucial to strong health
systems. In most Indian states, local health systems are
increasingly being strengthened through decentralisation
reforms and understanding how such local initiatives at
district and sub-district levels work is crucial to improving
responsiveness of health systems to emerging challenges
of providing good quality NCD care.
Access to medicines is much more than ensuring
availability. In spite of free medicines and care at PHCs
on paper, various reasons related to availability of ser-
vices, acceptability of care, health-seeking behaviour of
patients and perceived and technical quality of medi-
cines and healthcare at government PHCs hinder utilisa-
tion of medicines, even where medicines are available. In
the present study, we hope to better understand how
this situation could be changed in favour of improving
access to medicines.
NCD in primary health care
Our intervention somewhat mirrors the much-criticized
vertical disease-control approach as it focuses on improv-
ing access to medicines for NCD patients specifically (and
thus not for patients presenting with other problems) and
on strengthening processes at the primary level for the care
of NCD patients specifically (and, again, not for patients
presenting with other problems), while not addressing the
various underlying reasons for the general under-per-
formance of local health systems. A more integrated and
less selective approach would have been more appropriate
in addressing PHC-wide issues in drugs management and
continuity of care rather than take up these issues only in
relation to NCDs. The intervention by highlighting NCDs
may in fact in some areas decrease focus on other services
or activities that are less in the picture and therefore less
well-resourced. To some extent, this may be addressed by
ensuring that the intervention warrants that health
workers privilege their existing services whenever there is
a need to choose one against the other. In terms of sus-
tainability of the intervention, since the most of the gov-
ernment health services in India do not currently provide
systematic care and follow-up for NCDs, we foresee that
the generation of research evidence and positive experi-
ences by the district team during the ATM interven-
tion may result in the incorporation of some of its
intervention activities into their annual action plans.
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